| Accession |
PRJCA010976 |
| Title |
A phase II study to evaluate the antitumor efficacy, safety, tolerability and pharmacokinetics of DZD9008 in patients with locally advanced or metastatic NSCLC harboring EGFR exon 20ins |
| Relevance |
Medical |
| Data types |
Variation
|
| Organisms |
Homo sapiens
Homo
|
| Description |
This study is a phase II, single-arm, multicenter study conducted in China to evaluate the antitumor efficacy, safety, Tolerability and pharmacokinetics in patients with locally advanced or metastatic NSCLC harboring EGFR exon 20ins. |
| Sample scope |
Single cell |
| Release date |
2022-09-01 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
mengzhao
wang (mengzhaowang@sina.com)
|
| Organization |
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Submission date |
2022-08-02 |
